Breaks Categories: Stock Spotlights

MondayApr 10, 2017 12:50 pm

NetworkNewsBreaks – Geron Corp. (NASDAQ: GERN) Shares Higher on Second Internal Data Reviews for Imetelstat Trials

Geron Corporation (NASDAQ: GERN) shares climbed 21% on news that the second internal data reviews of the company’s IMerge and IMbark clinical trials have been completed by Janssen Research & Development, LLC. IMerge, the study of the telomerase inhibitor imetelstat in lower risk myelodysplastic syndromes (MDS), demonstrated that the benefit/risk profile of imetelstat in the treated patients supports continued development. The company intends to provide the FDA with a data package and proposed trial design refinements. For IMbark, a study of imetelstat in relapsed or refractory myelofibrosis (MF), current data suggest clinical benefit and a potential overall survival benefit. The…

Continue Reading

MondayApr 10, 2017 10:44 am

NetworkNewsBreaks – MGX Minerals, Inc. (MGXMF) Commences Unitization of Oil and Gas Leases in Utah’s Paradox Basin

Diversified mining company MGX Minerals, Inc. (OTC: MGXMF) this morning offered a project development update for its Paradox Basin petrolithium project. Notably, the company has begun unitization of designated oil and gas leases and the staking of overlying mineral claims located contiguous to its Lisbon Valley mineral claims. The purpose of these efforts is to eliminate existing property boundaries and pool mineral interests in order to establish MGX’s private partner as unit operator. Per the news release, consolidation of the oil and gas leases represents the most efficient timelines and cost-effective means of developing the area’s underlying resources. In total,…

Continue Reading

MondayApr 10, 2017 9:16 am

NetworkNewsBreaks – Singlepoint, Inc. (SING) Comments on Proposed Congressional Legislation to Regulate Marijuana

In March, Congress introduced legislation to regulate and tax marijuana, and to remove it from the federal Controlled Substances Act. SinglePoint, Inc. (OTC: SING) CEO Greg Lambrecht recently commented on how the proposed legislation could affect the company. SinglePoint has seen much revenue potential in the realm of legal cannabis, and hopes measures will be taken to streamline federal and state oversight of the market. Its interests go beyond investing. The congressional push should also help boost the value of its SingleSeed (www.SingleSeed.com) payments solutions for businesses in the cannabis industry. ‘For the near term, the best way the administration…

Continue Reading

FridayApr 07, 2017 12:56 pm

NetworkNewsBreaks – Yippy, Inc. (YIPI) Secures Compression Software and Technology Deal with Globalstar (NYSE: GSAT)

Shares of Yippy (OTC: YIPI) are up 9% on news that it will support Globalstar, Inc.'s (NYSE: GSAT) initiative to market its compression software and intranet data services. Yippy also noted that it recently completed production level environment for Globalstar's Generation 2 network, surpassing performance requirements. Yippy's software platform features advanced data compression technology that significantly decreases webpage load times for Internet access and intranet document retrieval. "Satellite bandwidth is a finite asset, and most satellite providers have an immediate need to reduce bandwidth overhead per subscriber across their networks. Our compression technology does just that, and is production ready…

Continue Reading

ThursdayApr 06, 2017 1:21 pm

NetworkNewsBreaks – MGX Minerals, Inc. (MGXMF) Develops Faster, Less Expensive Lithium Extraction Method

MGX Minerals (OTC: MGXMF) is set to tackle the growing lithium market with its new extraction technology capable of addressing environmental concerns along with the demand for lithium supply. “This innovative company is poised to ignite a revolution in the energy sector with technology that extracts lithium from oil and gas wells. Its PetroLithium™ methodology separates valuable minerals from the salt water that typically accompanies crude oil, offering a novel way to extract lithium, an essential ingredient in the batteries of our laptops, mobile phones, and other electronic devices and, increasingly, our cars. As MGX refines its technology, it is…

Continue Reading

ThursdayApr 06, 2017 12:46 pm

NetworkNewsBreaks – Nova LifeStyle, Inc. (NASDAQ: NVFY) Opens New Facility in Hong Kong Following Record-Breaking Monthly Members Sign-ups; Shares Soar

Nova LifeStyle (NASDAQ: NVFY) shares surged 48% on the company’s report of a record amount of new paying customers and student members signing up for its online and classroom-based Blockchain programs during the month of March. The company reported more than 2,000 new sign-ups in March, doubling its enrollment from February sign-ups. Additionally, the company recently opened its Digital Assets Cultural Hall in Kwun Tong, Hong Kong which is designed to accommodate customers seeking to participate in Nova’s Blockchain training program. “We continue to see strong customer and student member sign-ups for our lecture-based programs as well as on our…

Continue Reading

WednesdayApr 05, 2017 1:45 pm

NetworkNewsBreaks – National Waste Management Holdings, Inc. (NWMH) Reducing Environmental Impact of Construction and Demolition Rubble

According to the Environmental Protection Agency (http://nnw.fm/WeFZ4), over 500 million tons of construction and demolition (C&D) debris were generated in 2014. National Waste Management Holdings, Inc. (OTC: NWMH) aims to reduce the impact these debris have on the environment while growing in vertical markets. “The company is focused on operating according to an eco-friendly business model that has been put in place to combat unnecessary waste in Florida and New York. To pursue its mission of being environmentally conscience with a focus on sustainability, NWMH is committed to inspecting all loads and sorting all the materials that arrive in its…

Continue Reading

TuesdayApr 04, 2017 3:49 pm

NetworkNewsBreaks – CytoDyn Inc. (CYDY) Advances PRO 140 to Provide a Better Quality of Life for HIV Patients

More than 34 million people have died from HIV since it was first discovered in 1981, according to Healthline (http://nnw.fm/i9ptS). Although there is no known cure for the disease, CytoDyn Inc. (OTCQB: CYDY) is advancing its drug candidate toward providing a better life for HIV patients. “PRO 140 is currently one of the most advanced experimental monoclonal antibodies for HIV treatment, and CYDY believes that it will be beneficial to patients with complicating issues, such as those with single or multi-drug resistant viruses or those who have difficulty sticking to a daily drug regimen, as well as those who can’t…

Continue Reading

TuesdayApr 04, 2017 11:19 am

NetworkNewsBreaks – Evoke Pharma (NASDAQ: EVOK) Moves Forward with Comparative Exposure PK Trial for Gimoti NDA Following Type A Meeting with FDA

Evoke Pharma (NASDAQ: EVOK) shares rallied as much as 11% this morning after the company provided details of its positive Type A meeting with the U.S. Food and Drug Administration (FDA). Evoke met with the FDA to finalize the design of the pivotal comparative exposure pharmacokinetic (PK) trial and to reach agreement on additional aspects of the Chemistry, Manufacturing & Controls (CMC) section of the New Drug Application (NDA) for Gimoti™ for the relief of symptoms associated with acute and recurrent diabetic gastroparesis in adult women. The pivotal comparative exposure PK trial will be conducted in healthy volunteers to demonstrate…

Continue Reading

TuesdayApr 04, 2017 11:17 am

NetworkNewsBreaks – Diffusion Pharmaceuticals, Inc. (NASDAQ: DFFN) Receives Patent for TSC in Five Hypoxia-Related Indications; Shares Rally

Shares of Diffusion Pharmaceuticals (NASDAQ: DFFN) surged as much as 23% this morning after the company announced that the U.S. Patent and Trademark Office (USPTO) has issued a key patent for the company’s lead drug candidate, trans sodium crocetinate (TSC). Diffusion’s existing patents currently include the use of TSC in oncology, stroke and neurodegenerative disease indications. The new patent increases coverage of the therapeutic use of TSC and other related compounds to five hypoxia-related conditions including congestive heart failure, chronic renal failure, acute lung injury, chronic obstructive pulmonary disease, and respiratory distress syndrome. “Receiving the patent from the USPTO validates…

Continue Reading